$NVLX previously announced it had contracted Fisher BioServices for the long-term storage of cells required for its Phase III clinical trials. Dr. Crabtree says this contract ensures the safety and availability of cells to be used in those trials, "The Fisher BioServices arrangement gives Nuvilex a safety net, because its facilities will be used for long-term cell storage of the critically important ifosfamide-activating cells that are essential for Nuvilex's pancreatic cancer treatment. Should circumstances occur where the cells are 'lost' at any point in the overall process of obtaining the requisite number of cells necessary for the clinical trials, the Company will be able to recover the cell line from Fisher BioServices and resolve the 'problem'." Disclaimer: http://alturl.com/3yt3r